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Abstract. We developed a simple technique for the measurement of the procoagulant activ-
ity exposed on the surface ofmacrophages. The cells are isolated, adhered to plastic surfaces,
and assayed in the same device. This approach allows us to study the microcoagulation on the
surface of intact macrophages by sensitive and specific clotting tests.
Introduction
Fibrin deposition has been shown to occur
in a variety of pathological situations of
proyen or suspected immunopathological
origin. Monocytes and macrophages have
been described to express procoagulant activ-
ity on their surface upon stimulation; the
other leucocytes do not display this behav-
iour [-10]. Combining these two facts it is
evident that a study ofthe procoagulant be-
haviour of monocytes and macrophages un-
der different experimental conditions proba-
bly will give us a deeper insight into the
mechanism of clotting activation under
pathological conditions.
Diflerent types of macrophage procoagu-
lant activity have been described, €.9.,
thromboplastinlike activity [l-3, 5, l1], fac-
tor X activating activity [6-91, and thrombin-
activating activity 12, 3, l0l. However, in
most studies the macrophage procoagulant
activity was determined after transfer of the
cells from the culture dish to the device in
which the test was carried out and/or after
lysis of the cells. These types of manipulation
of the cells will certainly introduce variables
not necessarily present in vivo, and this
makes the interpretation of the physiological
meaning of the results more difficult. We,
therefore, designed a procedure in which the
in vitro handling of the cells was reduced to a
minimum. After the usual isolation proce-
dure the cells are seeded in small plastic tubes
instead of in culture Petri plates. The mea-
surement of the cellular procoagulant activity
can then be carried out in the same culture
tube after discarding the medium. This ap-
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proach enables us to determine the cellular
procoagulant activity of the adhering cells
without detaching and transferring them.
Materials and Methods
Only analytical-grade chemicals were used; all so-
lutions were prepared in distilled water.
Animals
Brown Norway rats (14-weeks-old females) bred
under pathogen-free conditions were used. One group
of animals was anticoagulated by the addition of war-
farin to the drinking water (2 mglml) during 3 weeks.
The degree of anticoagulation of the rats was deter-
mined in a species-specific test system [2].
Isolation and Culture of Cells
Rat spleen macrophages were obtained according
to the method of Boyum [13]. Rat peritoneal macro-
phages were obtained by peritoneal washing with hep-
arinized Hanks' solution (free of Ca2* and Mg2*). Rat
alveolar macrophages were obtained by pulmonary
washing with heparinized Hanks' solution (free of
Ca2* and Mg2*). Macrophage preparations were puri-
fred using Percoll gradient centrifugation (3G-80 0/o af-
ter red cell lysis with NHrCI: 0.16 mol/l).
Cells were routinely cultured in RPMI supple-
mented with l0o/o fetal calf serum and seeded in plas-
tic culture tubes (50 mm high; diameter l0 mm; 2 X
105 cells seeded/tube; volume 0.2 ml). After 2 h cul-
ture in an atmosphere of 5 0/o COz in air the superna-
tant containing the non-adherent cells was discarded
and replaced by serum-free medium. Incubations were
carried out at 37 " C in an atmosphere of 5 0/o COz in
air. Analysis of the cell composition was performed on
cytocentrifuge preparations stained with Giemsa or
non-specific esterase [4]. At least 200 cells were
counted per slide. The purity ofthe macrophage prep-
arations was at least 960/o. The viability of the cells as
assessed by trypan blue exclusion was at least 97 o/o.
Culture medium
This consisted of RPMI 1640 medium (Flow Lab-
oratories), penicillin (Gibco; final concentration 100
IUlml), transferrin (Behringwerke; final concentration
10 pelml), and albumin (Behringwerke; final concen-
tration 0.4 mglml). In several experiments this culture
medium was supplemented with additional com-
pounds; the exact composition of the culture medium
will be specified in the description of the individual
experiments. Culture medium and reagents were free
from endotoxin contamination as determined by a
chromogenic substrate endotoxin assay (Kabi Vitrum
Diagnostica) [15].
Measurement of Procoagulant Activity
Procoagulant activity was always determined in
the species-specific test system that has been described
by van Dam-Mieras et al. [2]. Procoagulant activity
exposed on the cellular surface was determined in the
plastic culture tube after removal of the culture me-
dium. The determination was carried out in the fol-
lowing way: pipette into the plastic tube containing the
adherent cells 0.2 ml standard plasma or factor-defi-
cient reagent diluted l: I with Michaelis buffer, incu-
bate at 37 'C during I 5 min and add 0. I ml CaCl2 (33
mmol/l), and register the clotting time.
The plasma procoagulant activity or procoagulant
activity secreted into the culture medium was deter-
mined in the following way: 0.1 ml sample, 0.1 ml
thromboplastin, 30 s incubation at 37 oC in a glass
tube, 0.1 ml CaCl2 (33 mmol/l), registration of the
clotting time.
For the determination of the activity of the indi-
vidual clotting factors the following experimental de-
sign was used in the determination of the factors II,
VII, and X: 0.1 ml sample diluted with Michaelis buff-
er, 0.1 ml factor-deficient plasma (II, VII or X), 0.1 ml
thromboplastin, 30 s incubation at 37 "C in a glass
tube,0.l ml CaCl2 (0.033 mmol/l), registration of the
clotting time.
The factor IX determination was carried out as fol-
lows: 0.1 ml sample diluted with Michaelis buller, 0.1
ml factor IX defrcient plasma, 0.1 ml aPTT reagent,
300 s incubation at 37 " C in a glass tube, 0. I ml CaClz
(0.033 mmol/l), registration of the clotting time.
The clotting factor levels are expressed in percent
of standard plasma by comparison of the clotting time
observed in the experiment with those obtained with a
series of dilutions of a standard plasma. All determi-
nations were carried out in triplicate.
Rat standard plasma was obtained by pooling
equal amounts of platelet-free plasma from 30 Brown
Norway rats and was stored in small portions at
-20"C until use [6]. Rat brain thromboplastin
(Brown Norway rats) was prepared as described before
[16]. Rat artificial factor II reagent was prepared
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according to the method of Koller et al. I I 7] using oxa-
lated rat plasma and rat serum.
Human standard plasma was obtained by pooling
equal amounts of platelet-free plasma from at least 30
healthy individuals (15 males and 15 females, average
age 30 years) and was stored in small portions at
-20'C prior to use [6]. Human brain thromboplas-
tin was prepared as described before [6]. Human arti-
ficial factor II reagent was prepared according to the
method of Koller et al. [7] using human oxalated
plasma and human serum. For the determination of
the clotting factors VII, IX, and X human congenital
factor deficient reagents were used. aPTT reagent was
obtained from Dade.
Results and Discussion
In order to be able to analyze the cellular
procoagulant activity of monocytes and mac-
rophages the isolation and assay procedures
have to be rigorously standardized. The stan-
dardization ofthe assay procedure has been
described before [2], and all the determina-
tions of macrophage procoagulant activity
described in this article are performed by
using a species-specilic test system.
Three diflerent macrophage populations
were isolated from Brown Norway rats: spleen
macrophages, peritoneal macrophages, and al-
veolar macrophages. The cells were cultured
in serum-free medium for 24hin the presence
of either vitamin K or warfarin, and after 24h
the procoagulant activity on the cellular sur-
face and the levels of the individual clotting
factors in the supernatant were determined.
The results are giYen in table I.
From table I it can be concluded that the
activity of vitamin K dependent clotting fac-
tors in the supernatant is completely abol-
ished by the addition of warfarin to the cul-
ture medium. The diflerence between the vi-
tamin K dependent factors on the one hand
and factor V on the other strongly suggests
that the coagulation factors are indeed se-
creted by the macrophage and that no aspe-
cific artefact is present. The presence of war-
farin in the culture medium has no influence
upon the amount of factor V found in the
supernatant. The addition of warfarin to the
culture medium also has a small, but very
reproducible inhibitory effect on the cellular
procoagulant activity. This suggests that, in
addition to thromboplastin, also some vita-
min K dependent procoagulant activity is
exposed on the surface.
It can also be seen from table I that mac-
rophages isolated from rat spleen show no, or
only minimal, cellular procoagulant activity,
while macrophages isolated from peritoneal
fluid and rat alveolar macrophages exhibit a
pronounced procoagulant activity. This dif-
ference in the cellular procoagulant activity
of macrophages isolated from different ana-
tomical sites has also been reported in the lit-
erature [8, 18] and is probably related to
functional differentiation of macrophages
and/or to the state of activation of the macro-
phage in the source organ.
In the experiments given in table II we
were obliged to test the rat macrophages in a
human test system, because no factor-defr-
cient plasmas are available from a rat source.
For reason of comparison the overall proco-
agulant activity is also measured in a human
standard plasma. The measurement of the
overall clotting activity in a rat standard
plasma gives clotting times that are apprecia-
bly shorter (about 20 s) than those obtained
with a human standard plasma.
It can be seen from table II that the pres-
ence of endotoxin in the culture medium
induces the expression ofprocoagulant activ-
ity on the surface of rat spleen macrophages.
This procoagulant activity may be expected
to be of the thromboplastin type Il-3, 5, 11].
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Table I. Comparison ofrat spleen, alveolar and peritoneal macrophages
Addition to
culture medium
Cellular
procoagulant
activity
Procoagulant activity in the supernatant
o/oll o/oVII o/olX o/oX o/oY
No cells (n = l0)
Vitamin K
Warfarin
Peritoneal macrophages (n = 5)
Vitamin K
Warfarin
Spleen macrophages (n = 8)
Vitamin K
Warfarin
Alveolar macrophages (n = 3)
Vitamin K
Warfarin
59.7 s
59.2 s
40.8 s
44.9 s
58.2 s
6 1 . 8  s
41 .0  s
45.2 s
<0 .5
<0 .5
l 0
<0 .5
t 2
<0 .5
I4
<0 .5
<0 .5
< 0.5
5
<0 .5
5
<0 .5
6
<0 .5
< 0.5
< 0.5
5 .5
<0 .5
6
<0 .5
5.5
< 0.5
< 0.5 < 0.5
< 0.5 < 0.5
1 0 6
<0 .5  6
t l
<0 .5  I
7 2
<0 .5  2
Macrophages were cultured in serum-free medium for 24 h; final concentration of additions: vitamin K
0.1 pglml; warfarin 12.5 1ry/ml.
Table II. Influence of endotoxin on the cellular procoagulant activity of rat spleen macrophages
Test plasma 1 2 3
Macrophages Macrophages plus Rat
4
Rat
endotoxin (100pg/ml) thromboplastin thromboplastin
Human standard plasma
II deficient (n = l)
V deficient (n = 2)
VII deficient (n = 2)
IX defrcient (n = 4)
X defrcient (n = 3)
VIII deficient (n = 6)
XI defrcient (n = 2)
XII deficient (n = 2)
148 s
10 min
4 8 s
240 s
1 7 5  s
245 s
190 s
4 6 s
170  s
7 5 s
8.5 min
4 0 s
232 s
130  s
245 s
221 s
4 6 s
145 s
148 s
10 min
160 s
235 s
192 s
265 s
150  s
149 s
200 s
7 4 s
10 min
8 2 s
159  s
1 1 2  s
1 8 3  s
7 6 s
7 5 s
l l 0  s
After purification and adhesion, the cells are incubated with culture medium (l) or with culture medium
supplemented with endotoxin (2) for 30 min. After the incubation the supernatant is discarded and the cellular
procoagulant activity is determined. The thromboplastin solution was diluted so as to give clotting times corre-
sponding to those of the non-stimulated and the stimulated macrophages.
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Endotoxin stimulation would than be equiv-
alent to an augmentation of the thromboplas-
tin concentration. In order to further charac-
terize the exposed cellular procoagulant ac-
tivity we compared it to thromboplastin
from the same species. In the last two col-
umns of table II the clotting times observed
when starting the clotting process by the ad-
dition of rat thromboplastin are shown. The
thromboplastin dilutions are chosen so as to
give the same clotting times as the unstimu-
lated and the stimulated macrophages, re-
spectively. If the macrophage procoagulant
activity were only of the thromboplastin
type, one would expect that the effect of
'thromboplastin dilution' on the cellular sur-
face (column 2 - column l) would lead to the
same result as the dilution of the rat throm-
boplastin suspension (column 4 - column 3).
Table II shows this is not the case. We have
no straightforward explanation for the ob-
served data, but one could tentatively explain
the results by the adsorption ofsecreted clot-
ting factors 14,5, l2l on the cellular surface.
Addition of endotoxin to the culture medium
would then result in tissue factor exposure
followed by the activation of the adsorbec
clotting factors. The one-stage clotting factor
determination measures the total amount of
clotting factors and does not discriminate be-
tween activated and non-activated clotting
factors because the factors are fully activated
during the test. Therefore, the differences be-
tween columns 2 and 1 are much smaller
than those between the columns 4 and 3 (Ia-
ble II). Also the observation that systemic
anticoagulation of rats by warfarin leads to a
reduction ofthe procoagulant activity on the
surface of peritoneal macrophages [9],
points in this direction. Finally, one might
wonder if the very reproducible frnding that
endotoxin stimulation of the macrophage
population results in an increased clotting
time when tested in a factor VIII deficient
reagent might point to the secretion and acti-
vation of the vitamin K dependent protein C
on the cellular surface [20]. Experiments to
further characterize the cellular procoagulant
activity of monocytes and macrophages are
presently being carried out.
The presence of hbrin deposits in a variety
of pathological situations necessitates a care-
ful analysis of the macrophage cellular pro-
coagulant activity and its generation during
stimulation of the cells. The early observa-
tion of B€guin et al. [1] that peritoneal mac-
rophages from sensitized animals 'shed'
more thromboplastin-like activity into the
supernatant during in vitro culture than peri-
toneal macrophages from non-sensitized
animals and our observation that anticoagu-
lation of the animal reduces the clearance
velocity of intraperitoneally injected virus
particles [9] both point to an active role of
macrophage procoagulant activity in the im-
mune defense reaction. The elucidation of
the physiological function of macrophage
procoagulant activity and insight in the pro-
cesses taking place at the cellular surface
might enable their therapeutic manipulation,
perhaps also through anticoagulation.
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